Have you received REBYOTA to keep recurrent C. diff from coming back? SHARE YOUR STORY>

Flowers on a vine Flowers on a vine Flowers on a vine

REBYOTA Support & Resources

Ferring Pharmaceuticals may offer financial assistance to qualified patients treated with REBYOTA.

REBYOTA Co-pay Program

Commercially insured, eligible PATIENTS MAY PAY AS LITTLE AS $100a for each REBYOTA prescription.

aAvailable only for patients who meet eligibility requirements. The program does not cover the cost of administration, office visits, or any associated costs. Terms and conditions apply. Offer expires 12/31/24.

See additional terms and conditions below.

To enroll in the REBYOTA Co-pay Program, please speak with your doctor.

For additional assistance, call 1-877-REBYOTA

REBYOTA Patient Assistance Programa

You may be eligible to receive REBYOTA at no cost if you qualify for the Ferring REBYOTA Patient Assistance Program (PAP). Simply ask your doctor’s office to enroll on your behalf through REBYOTA Connect.

aAvailable only for patients who meet eligibility requirements. The program does not cover the cost of administration, office visits, or any associated costs. Terms and conditions apply. Offer expires 12/31/24.

See additional terms and conditions below.

To learn more about the REBYOTA Patient Assistance Program and to see if you qualify, please speak with your doctor.

Patient Testimonials

See how REBYOTA has helped people keep recurrent C. diff infection from coming back. These are some of their inspiring stories.

Melissa’s story

“Had this treatment been available sooner, I would have asked for it.”

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Melissa was compensated for her time. Individual results may vary.

Melissa’s Story Video: Her Journey to REBYOTA Treatment

Freda’s story

“I just knew that if I had C. diff again, I wasn’t going to survive. But my C. diff didn’t come back after I had my treatment.”

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Freda was compensated for her time. Individual results may vary.

Freda’s Story Video: Her Journey to REBYOTA Treatment

Patricia’s story

“For me it was one dose and one visit, and that was it. I was able to hug and squeeze my girls again.”

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Patricia was compensated for her time. Individual results may vary.

Patricia’s Story Video: Her Journey to REBYOTA Treatment

Marty’s story

“After REBYOTA, my symptoms never came back. I’ve had no recurrences.”

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Marty was compensated for his time. Individual results may vary.

Marty’s Video: His Road to Recovery with REBYOTA

Share Your REBYOTA Treatment Story

Have you been treated with REBYOTA and want to share your story with others?
Fill out the form below and we will contact you for more information.

Preferred communication method*(Required)
Have you or a loved one been treated with REBYOTA?*(Required)

*Required field.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Consent(Required)

Frequently Asked Questions

What is REBYOTA?

Before Treatment

During Treatment

After Treatment

Insurance/Financial Support

Flowers on a vine

This is Patricia’s Story

This is Patricia’s Story

I was finally able to tuck my girls into bed again. I read them a story and had lots of snuggles.

- Patricia, Clinical Study Patient

Watch Patricia’s Story

Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.

For more information, please talk to your doctor and see full Prescribing Information. Patricia was compensated for her time. Individual results may vary.

Patricia’s Story Video: Her Journey to REBYOTA Treatment

Have you also been treated with REBYOTA? SHARE YOUR STORY>

Helpful Resources

Resources to help you and others (including caregivers) who may be coping with C. diff infection.

C-diff Caregiver Checklist

Advocate for a Loved One

Here is a Caregiver Checklist to help get you started.

Download
C-diff Patient Diary

Track Your Progress

A diary for recording your
C. diff infection experiences.

Download

Join an Online Research Panel

Have you suffered with C. diff or cared for someone who has? Or have you recently been treated with REBYOTA? If so, please join an online research panel and help others living with C. diff.

Flowers on a vine Flowers on a vine

If you’re ready to talk to a doctor, this customized discussion guide is a great way to prepare.

Sign up for more information

Receive additional information and resources to help you through your C. diff infection journey.

What’s your experience with C. diff infection?*(Required)

*Required field.

Consent(Required)

References

  1. REBYOTA. Prescribing Information. Parsippany, NJ: Ferring Pharmaceuticals Inc; 2022.
  2. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infection. Am J Gastroenterol. 2013;108(4):478-498.
  3. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1-e48.

Please see Important Safety Information and full Prescribing Information

INDICATION

REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.

Important Safety Information

  • You should not receive REBYOTA if you have a history of a severe allergic reaction (e.g., anaphylaxis) to REBYOTA or any of its components.
  • You should report to your doctor any infection you think you may have acquired after administration.
  • REBYOTA may contain food allergens.
  • Most common side effects may include stomach pain (8.9%), diarrhea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).
  • REBYOTA has not been studied in patients below 18 years of age.
  • Clinical studies did not determine if adults 65 years of age and older responded differently than younger adults.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.

Please click to see the full Prescribing Information

You are leaving REBYOTA.com

The link you have selected will direct you to a site or resource outside of our website.
Thank you.